A comprehensive view of Sage Therapeutics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sage Therapeutics to participate in upcoming May investor conferences
Published: May 07, 2024 by Sage Therapeutics
Sage Therapeutics announces first quarter 2024 financial results and highlights pipeline and business progress
Published: April 25, 2024 by Sage Therapeutics
Sage Therapeutics announces topline results from Phase 2 PRECEDENT Study of Dalzanemdor SAGE-718 in the treatment of mild cognitive impairment in Parkinson’s disease
Published: April 17, 2024 by Sage Therapeutics
Sage Therapeutics to report first quarter 2024 financial results on Thursday, April 25, 2024
Published: April 11, 2024 by Sage Therapeutics
Sage Therapeutics announces Dr. Steve Paul to retire from Board of Directors on June 10, 2024
Published: March 26, 2024 by Sage Therapeutics

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count